AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

China NMPA approves Sanofi & Regeneron’s Dupixent as an add-on maintenance treatment for adults with uncontrolled COPD: Paris Monday, September 30, 2024, 11:00 Hrs [IST] The Nat ...

The National Medical Products Administration approved Dupixent as an add-on maintenance treatment for adults with ...

Adding daratumumab to lenalidomide in maintenance therapy for multiple myeloma significantly reduced rates of minimal ...

The Ministry of  Health (MoH) and the Ghana Health Service (GHS) have launched the AYA-Integrated Healthcare Initiative (IHI) ...

AT A finance conference in London this summer, four senior investment bankers set about persuading the room that the ...

AM(IST)on Monday in a weak market. J B Chemicals & Pharmaceuticals Ltd.(up 2.83 per cent), Sanofi India Ltd.(up 1.36 per cent ...

KT-621 has the potential to provide dupilumab-like activity with an oral small molecule profile for TH2 driven allergic and atopic disease KT-621 demonstrated strong degradation of STAT6 in human ...

The United Kingdom Children’s Health Supplement Market is projected to reach a valuation of USD 156.8 million by 2034, with a ...

TopBuild Corp. is a construction company poised for growth with record revenue and a flexible cost structure. Learn more ...

For 13 years, Molly King has depended on an insulin drug to manage her Type 1 diabetes. On Dec. 31, that drug will be wiped ...

Hitchiner, in partnership with PROCON’s integrated design and construction team, has officially broken ground on a new 57,000 ...